These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3544320)

  • 1. [Per os effects of bepridil on venous compliance in a controlled double-blind cross-over trial versus placebo].
    Bailliart O; Tessera M; Martineaud JP; Castan D
    Therapie; 1986; 41(5):385-90. PubMed ID: 3544320
    [No Abstract]   [Full Text] [Related]  

  • 2. Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo.
    Canty P; Valentine J
    J Laryngol Otol; 1981 Jul; 95(7):687-92. PubMed ID: 7019369
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of Buflomedil on the cutaneous microcirculation studies by a cold provocation test. Multicenter, double-blind, placebo controlled trial].
    Maurel A; Betrancourt JC; Van Frenkel R; Thuillez C
    J Mal Vasc; 1995; 20(2):127-33. PubMed ID: 7650439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of buflomedilhydrochloride (Loftyl) on temporary hearing threshold shift.
    Axelsson A; Lindgren F
    Scand Audiol Suppl; 1986; 26():37-40. PubMed ID: 3554485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of BTS 49465 on blood pressure and peripheral arteriolar and venous tone in normal volunteers.
    Cowley AJ; Wynne RD; Hampton JR
    J Hypertens Suppl; 1984 Dec; 2(3):S547-9. PubMed ID: 6599715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic focus: bepridil].
    Woler C
    Ann Cardiol Angeiol (Paris); 1984; 33(4):245-6. PubMed ID: 6380383
    [No Abstract]   [Full Text] [Related]  

  • 7. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nifedipine in the treatment of essential hypertension].
    Condorelli M; Bonaduce D; Ferrara N; Petretta M; De Caprio L; Rengo F
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II7-12. PubMed ID: 6763269
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy and tolerance of a bepridil challenge dose. A double-blind multicenter study].
    Apoil E; Arstila M; Dettmer A; Graf N; Keyrilainen O; Marcadet DM; Neuhaus R; Oversohl K; Rudroff W; Sack DW
    Ann Cardiol Angeiol (Paris); 1986; 35(7):403-7. PubMed ID: 3541768
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new antianginal drug, bepridil: efficacy estimation by exertion test during a double blind test against a placebo (author's transl)].
    Canicave JC; Deu J; Jacq J; Paillet R
    Therapie; 1980; 35(5):607-12. PubMed ID: 6970998
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
    Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of Bepridil on respiratory and cardiovascular function: a placebo-controlled study.
    Forche G; Kopera H; Marsoner HJ
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):234-40. PubMed ID: 6602783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double-blind cross-over clinical study of a new psychopharmaceutic agent: thiadipone (QM-6008), diazepam and a placebo].
    Conde López V
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1980; 8(6):409-42. PubMed ID: 7008536
    [No Abstract]   [Full Text] [Related]  

  • 14. Practical aspects of clinical trials: a review of a randomized, placebo-controlled study in patients with heart failure.
    Murphy J; Coxon R; Sharpe DN
    Heart Lung; 1985 Jan; 14(1):95-100. PubMed ID: 2981789
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate in mild depression: a double-blind controlled trial.
    Mattes JA
    J Clin Psychiatry; 1985 Dec; 46(12):525-7. PubMed ID: 3905773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome.
    Vincent JL; Brase R; Santman F; Suter PM; McLuckie A; Dhainaut JF; Park Y; Karmel J
    Intensive Care Med; 2001 Oct; 27(10):1578-83. PubMed ID: 11685297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of cross-tolerance to short-term linsidomine in forearm resistance vessels and dorsal hand veins in subjects with nitroglycerin tolerance.
    Sütsch G; Kim JH; Bracht C; Kiowski W
    Clin Pharmacol Ther; 1997 Nov; 62(5):538-45. PubMed ID: 9390110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double-blind and cross-over studies with a new drug (67350 M.D.) in peripheral angiopathy].
    Bremer C
    Med Welt; 1974 Oct; 25(43):1770-3. PubMed ID: 4607677
    [No Abstract]   [Full Text] [Related]  

  • 19. Penicillamine in ankylosing spondylitis: a double blind placebo controlled trial.
    Steven MM; Morrison M; Sturrock RD
    J Rheumatol; 1985 Aug; 12(4):735-7. PubMed ID: 3903158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.